Avricore Health Inc(AVCR-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.070
Day High0.070
Open:0.070
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Avricore Health Closes $1.254 Million Financing
Avricore Health Announces $1.25 Million Financing
Upcoming Meeting Dates - May 18, 2026
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform
HealthTab™ to Expand Across North East London
HealthTab™ to Power NHS Pilot
Avricore Health’s HealthTab™ Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project
Avricore Grants Options
Avricore Appoints Rodger Seccombe as CEO
AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track

Profile

Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The company has only one segment, being the HealthTab - Point of Care Business in Canada. The company's revenues are generated from operating leases of the POCT system and the sale of testing panels. Geographically, the company operates in Canada and United Kingdom, it derives maximum revenue Canada.